Who invested in De novo Biotherapeutics?
De novo Biotherapeutics's investors include Ridge Ventures, Stonebridge Ventures and Atinum Investment.
Who invested in De novo Biotherapeutics
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$5.8Mraised across 1 round since 2022, from 1 source
- Latest round
- Series A, $5.8MNov 2022
- Investors
- 3
The rounds
- Nov 2022
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about De novo Biotherapeutics
How much has De novo Biotherapeutics raised?
De novo Biotherapeutics has raised $5.8M across 1 round since 2022.
When did De novo Biotherapeutics last raise?
De novo Biotherapeutics's most recent round was a Series A of $5.8M in Nov 2022.
What was De novo Biotherapeutics's biggest round?
Its most recent round, $5.8M in Nov 2022, is also its largest on record.
Who backed De novo Biotherapeutics first?
De novo Biotherapeutics's first round on record, in Nov 2022, was backed by Ridge Ventures, Stonebridge Ventures and Atinum Investment.
What stage is De novo Biotherapeutics at?
De novo Biotherapeutics's latest named round is a Series A, in Nov 2022.
Companies like De novo Biotherapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.